Alexion Pharmaceuticals (ALXN) PT Lowered to $127 at Morgan Stanley
Tweet
Share
E-mailGet Alerts ALXN Hot Sheet
Price: $182.01 --0%
Rating Summary:
10 Buy, 25 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 10 | Down: 18 | New: 20
Rating Summary:
10 Buy, 25 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 10 | Down: 18 | New: 20
Join SI Premium – FREE
Morgan Stanley analyst Matthew Harrison lowered the price target on Alexion Pharmaceuticals (NASDAQ: ALXN) to $127.00 (from $131.00) while maintaining a Equalweight rating.
You May Also Be Interested In
- Aebi Schmidt Holding AG (AEBI) PT Raised to $17 at DA Davidson Following Q2 Results
- Semiconductor Manufacturing International Corp. (981:HK) (SMI) PT Raised to HK$153 at Goldman Sachs
- Yum! Brands (YUM) PT Lowered to $180 at Argus
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
